Med Clin North Am. 2023 May;107(3):623-640. doi: 10.1016/j.mcna.2022.12.008. Epub 2023 Feb 20.
ABSTRACT
Biological agents have in the last two decades become very important therapeutic agents, particularly for the treatment of various autoimmune disorders. The most widely used biologics are the tumor necrosis factor-α (TNF-α) receptor antagonists: infliximab, adalimumab, and etanercept. Other commonly used biological agents are interleukin (IL)-1 receptor antagonist (Anakinra), interleukin (IL)-6 receptor antagonist (tocilizumab), and CD20 surface antigen antagonist (rituximab). The current review will however focus on TNF-α receptor antagonists.
PMID:37001957 | DOI:10.1016/j.mcna.2022.12.008